PharmaRelations ApS — Credit Rating and Financial Key Figures
CVR number: 38215663
Hummeltoftevej 49, 2830 Virum
kim.raabymagle@pharmarelations.dk
tel: 51199197
www.pharmarelations.dk
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 8 595.39 | 14 605.54 | 20 105.09 | 23 599.55 | 23 251.52 |
| Employee benefit expenses | -7 929.15 | -12 545.09 | -16 735.56 | -22 633.82 | -22 218.78 |
| Total depreciation | -71.43 | -71.43 | -71.43 | -71.43 | -71.43 |
| EBIT | 594.81 | 1 989.02 | 3 298.10 | 894.30 | 961.32 |
| Other financial expenses | -14.27 | -50.39 | -24.34 | -28.64 | -64.68 |
| Pre-tax profit | 580.54 | 1 938.64 | 3 273.76 | 865.66 | 896.64 |
| Income taxes | - 150.69 | - 444.75 | - 720.21 | - 191.07 | - 197.25 |
| Net earnings | 429.85 | 1 493.88 | 2 553.55 | 674.59 | 699.39 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Goodwill | 285.71 | 214.28 | 142.86 | 71.43 | |
| Intangible assets total | 285.71 | 214.28 | 142.86 | 71.43 | |
| Tangible assets total | |||||
| Other receivables | 63.59 | 102.58 | 151.71 | 246.64 | 212.51 |
| Investments total | 63.59 | 102.58 | 151.71 | 246.64 | 212.51 |
| Long term receivables total | |||||
| Inventories total | |||||
| Current trade debtors | 2 945.90 | 4 324.99 | 6 611.45 | 7 619.78 | 8 018.00 |
| Prepayments and accrued income | 101.50 | 188.94 | 496.23 | ||
| Current other receivables | 100.27 | 0.22 | 8.50 | ||
| Current deferred tax assets | 14.75 | ||||
| Short term receivables total | 3 046.17 | 4 324.99 | 6 712.95 | 7 808.94 | 8 537.47 |
| Cash and bank deposits | 1 603.43 | 3 683.84 | 2 047.46 | 459.85 | 1 239.71 |
| Cash and cash equivalents | 1 603.43 | 3 683.84 | 2 047.46 | 459.85 | 1 239.71 |
| Balance sheet total (assets) | 4 998.91 | 8 325.70 | 9 054.98 | 8 586.86 | 9 989.68 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 50.00 | 50.00 | 50.00 | 50.00 | 50.00 |
| Retained earnings | 420.41 | 850.26 | 2 344.15 | 4 897.69 | 5 572.28 |
| Profit of the financial year | 429.85 | 1 493.88 | 2 553.55 | 674.59 | 699.39 |
| Shareholders equity total | 900.26 | 2 394.15 | 4 947.69 | 5 622.28 | 6 321.67 |
| Non-current owed to group member | 1 588.73 | ||||
| Non-current liabilities total | 1 588.73 | ||||
| Current loans from credit institutions | 17.60 | 29.74 | 30.17 | 56.79 | 17.78 |
| Current trade creditors | 501.83 | 377.86 | 779.50 | 999.81 | |
| Short-term deferred tax liabilities | 137.70 | 376.75 | 676.21 | 71.95 | |
| Other non-interest bearing current liabilities | 2 354.62 | 5 023.23 | 3 023.05 | 2 056.33 | 2 650.42 |
| Current liabilities total | 2 509.91 | 5 931.55 | 4 107.28 | 2 964.58 | 3 668.01 |
| Balance sheet total (liabilities) | 4 998.91 | 8 325.70 | 9 054.98 | 8 586.86 | 9 989.68 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.